Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label
publisher	pref label
tabling member	label

Search

418463

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:32
	ddp modified	16/09/2015 12:18:04
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hidradenitis Suppurativa
	house id	1
	identifier	10010
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 11:46:53
	question text	To ask the Secretary of State for Health, what steps NHS England takes to assess the health and social care needs of patients with hidradenitis suppurativa; and what assessment he has made of the ability of the NHS to deliver efficient diagnosis and access to specialist care for such patients.
	session	2015/16
	session number	1
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	title	House of Commons Tabled Parliamentary Question 2015/16 10010
	type	WrittenParliamentaryQuestion
	uin	10010
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	1538 label Biography information for Rosie Cooper
	publisher	25259 pref label House of Commons
	tabling member	1538 label Biography information for Rosie Cooper

418464

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:33
	ddp modified	16/09/2015 12:18:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hidradenitis Suppurativa
	house id	1
	identifier	10011
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 11:46:53
	question text	To ask the Secretary of State for Health, what progress has been made by NHS England on the production of a commissioning policy for treatments associated with hidradenitis suppurativa; what the proposed scope of that policy is; and when he expects that policy to have been fully developed.
	session	2015/16
	session number	1
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	title	House of Commons Tabled Parliamentary Question 2015/16 10011
	type	WrittenParliamentaryQuestion
	uin	10011
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	1538 label Biography information for Rosie Cooper
	publisher	25259 pref label House of Commons
	tabling member	1538 label Biography information for Rosie Cooper

418446

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:18
	ddp modified	17/09/2015 10:39:01
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Eyesight: Testing
	house id	1
	identifier	10017
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	17/09/2015 10:07:37
	question text	To ask the Secretary of State for Health, how many people were diagnosed with (a) a brain tumour and (b) other conditions as a result of symptoms noticed during examinations by opticians in the last 12 months.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10017
	type	WrittenParliamentaryQuestion
	uin	10017
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418450

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:21
	ddp modified	16/09/2015 15:47:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	identifier	10022
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:15:57
	question text	To ask the Secretary of State for Health, what criteria NICE has set for new dementia treatments to be recommended for provision by the NHS.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10022
	type	WrittenParliamentaryQuestion
	uin	10022
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418451

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:23
	ddp modified	16/09/2015 15:54:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	10091
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:22:40
	question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the decision by NHS England announced on 4 September 2015 to remove (a) the pancreatic cancer drug Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund list of approved drugs.
	session	2015/16
	session number	1
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	title	House of Commons Tabled Parliamentary Question 2015/16 10091
	type	WrittenParliamentaryQuestion
	uin	10091
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	4056 label Biography information for Nic Dakin
	publisher	25259 pref label House of Commons
	tabling member	4056 label Biography information for Nic Dakin

418452

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:23
	ddp modified	16/09/2015 15:55:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	10092
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:23:43
	question text	To ask the Secretary of State for Health, what mechanisms there are for appeal against NHS England's decision announced on 4 September 2015 to remove (a) Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund list of approved drugs; and if he will make a statement.
	session	2015/16
	session number	1
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	title	House of Commons Tabled Parliamentary Question 2015/16 10092
	type	WrittenParliamentaryQuestion
	uin	10092
	version	2
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	4056 label Biography information for Nic Dakin
	publisher	25259 pref label House of Commons
	tabling member	4056 label Biography information for Nic Dakin

418453

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:24
	ddp modified	16/09/2015 15:57:03
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	10093
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:25:30
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect on cancer clinical trials of NHS England's decision announced on 4 September 2015 to remove (a) Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund list of approved drugs; and if he will make a statement.
	session	2015/16
	session number	1
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	title	House of Commons Tabled Parliamentary Question 2015/16 10093
	type	WrittenParliamentaryQuestion
	uin	10093
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	4056 label Biography information for Nic Dakin
	publisher	25259 pref label House of Commons
	tabling member	4056 label Biography information for Nic Dakin

418459

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:29
	ddp modified	16/09/2015 12:33:04
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ophthalmic Services
	house id	1
	identifier	9977
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 12:01:58
	question text	To ask the Secretary of State for Health, what funding his Department provides for eye clinic liaison officers.
	session	2015/16
	session number	1
	tabling member constituency	Tewkesbury
	tabling member printed	Mr Laurence Robertson
	title	House of Commons Tabled Parliamentary Question 2015/16 9977
	type	WrittenParliamentaryQuestion
	uin	9977
	version	2
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	253 label Biography information for Mr Laurence Robertson
	publisher	25259 pref label House of Commons
	tabling member	253 label Biography information for Mr Laurence Robertson

418460

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:30
	ddp modified	16/09/2015 16:01:01
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Multiple Births
	house id	1
	identifier	9978
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:29:19
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the (a) extent and (b) effectiveness of sharing of best practice of implementation of guidance on multiple pregnancies between NHS hospital trusts.
	session	2015/16
	session number	1
	tabling member constituency	Tewkesbury
	tabling member printed	Mr Laurence Robertson
	title	House of Commons Tabled Parliamentary Question 2015/16 9978
	type	WrittenParliamentaryQuestion
	uin	9978
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	253 label Biography information for Mr Laurence Robertson
	publisher	25259 pref label House of Commons
	tabling member	253 label Biography information for Mr Laurence Robertson

418458

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:28
	ddp modified	16/09/2015 12:33:03
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ophthalmic Services
	house id	1
	identifier	9980
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 12:01:58
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the effect of eye clinic liaison officers on improving patient health and social care; and what progress he has made on increasing the provision of such officers.
	session	2015/16
	session number	1
	tabling member constituency	Tewkesbury
	tabling member printed	Mr Laurence Robertson
	title	House of Commons Tabled Parliamentary Question 2015/16 9980
	type	WrittenParliamentaryQuestion
	uin	9980
	version	2
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	253 label Biography information for Mr Laurence Robertson
	publisher	25259 pref label House of Commons
	tabling member	253 label Biography information for Mr Laurence Robertson